Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Kaan Low
Observed name:
Low, Kaan
Institution:
Institute of Cancer Research
Observed institutions:
Institute of Cancer Research,
Middlesex University London
ORCID:
0000-0003-4275-660X
Observed ORCID:
0000-0003-4275-660X
OpenAlex ID:
A5000811604
The efficacy of gemcitabine and docetaxel chemotherapy for the treatment of relapsed and refractory osteosarcoma: A systematic review and pre‐clinical study
2024
·
Kaan Low
, Paola Foulkes
, et al.
·
Cancer Medicine
·
11
PDF
Establishment and Characterization of Single and Triple‐Agent Resistant Osteosarcoma Cell Lines
2022
·
Kaan Low
, Frank Hills
, et al.
·
Advanced Biology
·
5
PDF
Exploiting collateral sensitivity in the evolution of resistance to tyrosine kinase inhibitors in soft tissue sarcomas
2025
·
Mark L. Elms
, Andrew D. Jenks
, et al.
·
Communications Biology
·
3
PDF
Proteomic features of soft tissue tumours in adolescents and young adults
2024
·
Yuen Bun Tam
, Kaan Low
, et al.
·
Communications Medicine
·
3
Show more works
View as search
Works count:
6
Citation count:
22
H-index:
3
I10-index:
1
Year
Topic
Type